US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  
Growth Potential of Specific Biomarker-Based Tests: White Paper
2/9/2016 | published by: Kalorama Information
... for all tests are provided, as well as a list of companies that are involved in the market.  Markers discussed include:  CEA, HIV Rapid Marker-Based, AFP, FOB, Rapid PSA, NMP22, Cardiac Markers-Acute, C difficile Marker-Based, ...  |  read more...
Biomarker-Based Tests: Faster Revenue Growth
2/26/2016 | published by: Kalorama Information
Tests with biomarker basis are demonstrating faster revenue growth than the IVD market.  This White Paper discusses the trend, and defines companies in the marketplace.  Based on Kalorama Informaton's Biomarker Market reporting.    |  read more...
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Global and Chinese Kidney marker Industry, 2016 Market Research Report
4/8/2016 | published by: Prof-Research
... market. The report provides key statistics on the market status of the Kidney marker manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides ...  |  read more...
USD 2,900
2016-2020 Immunodiagnostics: Spot Fast-Growing Market Segments - Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
3/18/2016 | published by: VPGMarketResearch.com
... future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares ...  |  read more...
USD 24,500
Exosome Diagnostics and Therapeutics: Global Markets
3/1/2016 | published by: BCC Research
... (CAGR) of 47.3%. This report provides: An overview of the global markets and related technologies for exosome diagnostics and therapeutics. Analyses of global market trends, with data from 2015, estimates for 2016, and projections of ...  |  read more...
USD 6,650
Solid Tumor Testing Market in the US 2016-2020
2/24/2016 | published by: TechNavio - Infiniti Research Ltd.
... body. The testing procedure involves testing of samples such as urine, blood, and other bodily substances. Further, cancer testing also involves conducting genetic tests to analyze certain gene mutations that are linked to certain cancer ...  |  read more...
USD 2,500
Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
3/1/2016 | published by: Current Partnering
... Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Global Biomarker Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to ...  |  read more...
USD 2,995
Global Commercializing Biomarkers Industry 2016 Market Research Report
3/18/2016 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Commercializing Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 2,850
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
3/1/2016 | published by: BCC Research
... of 10.4%. This report provides: An overview of the global market for central nervous system (CNS) biomarkers, which are measurable and quantifiable biological indicators that can be used to diagnose or predict disease, monitor disease ...  |  read more...
USD 6,650
The Global Market for Biomarkers (Cancer Markers, Cardiac Markers, Immunological Disease Markers, Infectious Disease Markers, Others)
12/10/2015 | published by: Kalorama Information
... markets for biomarkers. The report provides a market analysis for six broad areas of medical biomarkers: The Market for Cancer Biomarkers The Market for Cardiovascular Disease Biomarkers The Market for Immunological Disease Biomarkers The Market ...  |  read more...
USD 4,200
Global Molecular Biomarkers Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Molecular Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 5,800
Global Central Nervous System (CNS) Biomarkers Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Central Nervous System (CNS) Biomarkers basics: definitions, classifications, applications and industry chain overview; ...  |  read more...
USD 2,850
Cancer Bundle
1/1/2016 | published by: TriMark Publications
... Diagnostic Testing World Markets. Cancer Therapeutics Markets. Cancer Vaccines Markets. Companion Diagnostics in Personalized Medicine and Cancer Therapy. Cytology and HPV Testing World Markets. Game Changers in Breast Cancer Therapies. Molecular Diagnostics in Cancer Testing. ...  |  read more...
USD 85,500
Global Cardiac Marker Diagnostic Testing Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cardiac Marker Diagnostic Testing basics: definitions, classifications, applications and industry chain overview; industry policies and ...  |  read more...
USD 5,800
POCT Market in the US 2015-2019
11/18/2015 | published by: TechNavio - Infiniti Research Ltd.
... the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays ...  |  read more...
USD 2,500
Global Biomarker Technology Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Biomarker Technology basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 5,800
Global Renal Biomarkers Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Renal Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 5,800
Global Cancer Biomarkers Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cancer Biomarkers basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 5,800
Global Tumor Profiling Technologies Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Tumor Profiling Technologies basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; ...  |  read more...
USD 5,800
Global Cancer/Tumor Profiling Industry 2015 Market Research Report
12/18/2015 | published by: 9Dimen Research
... Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Cancer/Tumor Profiling basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ...  |  read more...
USD 5,800
MicroRNAs in Cancer Drug Pipeline Update
2/1/2016 | published by: BioSeeker Group AB
... minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us and ...  |  read more...
USD 6,750
Global Central Nervous System (CNS) Biomarkers by Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation and Forecast 2015 – 2021
11/13/2015 | published by: Occams Business Research & Consultancy
... proteomics, genomics and imaging system has increased demand for CNS biomarker says a new report by Occams Research. Global gene expression profiling by genomic and proteomic analyses has changed the face of drug discovery and ...  |  read more...
USD 4,000
Analysis of the Cardiac Biomarker Diagnostics Market
9/30/2015 | published by: Frost & Sullivan
... conducted with vice presidents (VPs) of business units, VPs of marketing, product managers, marketing managers, marketing directors, and business development directors from various competitors within different cardiac diagnostic segments. Industry-specific information that was obtained includes: ...  |  read more...
USD 4,950
2015-2019 World Tumor Marker Diagnostic Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
6/26/2015 | published by: VPGMarketResearch.com
... of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 2,500
< prev 1    3  4  5  6  7  8